Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.49 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | CCR4 | P51679 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2722654 | 0.84 | HTT (0.48) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL5163824 | 0.81 | MAPT (0.50) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL13979173 | 0.81 | MAPT (0.50) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL1275442 | 0.80 | PDK1 (0.47) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL15285454 | 0.77 | PDK1 (0.49) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL10353046 | 0.74 | MAPT (0.43) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL6716559 | 0.74 | HTT (0.43) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL19570403 | 0.74 | MAPT (0.54) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL11079881 | 0.71 | HPGD (0.54) | PDK1PDK2PDK3PDK4HTT | |
| SCHEMBL17936482 | 0.71 | MAPT (0.45) | PDK1PDK2PDK3PDK4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10886477-B2 | Iridium complex and organic electroluminescence device using the same | UDC IRELAND LIMITED (IE) | 2021-01-05 | — | — | US | disclosed |
| US-20190296251-A1 | IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296251-A1 | IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IMPA1, LAGE3, OCIAD1 | PDK1 174/4885PDK2 632/4885PDK3 778/4885 |
| US-10886477-B2 | Iridium complex and organic electroluminescence device using the same | IMPA1, LAGE3, OCIAD1 | PDK1 174/4885PDK2 632/4885PDK3 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.